by Marnet Team | Mar 5, 2026 | Regulatory, News
SystImmune and Bristol Myers Squibb announce interim Phase III data showing Iza-bren significantly improves outcomes in previously treated triple-negative breast cancer (TNBC) patients. SystImmune, Inc. and Bristol Myers Squibb have announced positive topline results...
by Marnet Team | Mar 5, 2026 | Regulatory, News
Evox Therapeutics Ltd collaborates with Rett Syndrome Research Trust to evaluate its ExoEdit® exosome-based gene editing platform as a potential therapeutic approach for Rett syndrome. Evox Therapeutics Ltd has announced the launch of a new strategic collaboration...
by Marnet Team | Mar 5, 2026 | Technology, News
New findings reinforce the clinical value of Aventa Lymphoma test for detecting diagnostically and therapeutically relevant genomic rearrangements in routine pathology samples. Arima Genomics, Inc., a precision oncology company harnessing whole-genome sequence and...
by Marnet Team | Mar 5, 2026 | Regulatory, News
New clinical study results highlight significant reductions in residual stone volume and follow-up health complications with Calyxo’s CVAC System. Calyxo, Inc., a medical device innovator transforming the treatment of kidney stones, has announced the peer-reviewed...
by Marnet Team | Mar 5, 2026 | News
ENDRA Life Sciences Demonstrates High Consistency in TAEUS® Liver Device for MASLD Monitoring ENDRA Life Sciences Inc , a leading innovator in thermoacoustic imaging technology, has reported highly favorable results from a recent clinical study evaluating the...
by Marnet Team | Mar 5, 2026 | News, Press Releases
Sierra Space Appoints Dan Jablonsky as Chief Executive Officer to Drive Next Phase of Growth Across National Security and Space Markets Sierra Space, a leading aerospace and defense technology company recognized for delivering critical solutions to the nation’s most...
